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Two cell type-specific Rab proteins, Rab32 and Rab38
(Rab32/38), have been proposed as regulating the trafficking of
melanogenic enzymes, including tyrosinase and tyrosinase-re-
lated protein 1 (Tyrp1), to melanosomes in melanocytes. Like
other GTPases, Rab32/38 function as switch molecules that
cycle between a GDP-bound inactive form and a GTP-bound
active form; the cycle is thought to be regulated by an activating
enzyme, guanine nucleotide exchange factor (GEF), and an inac-
tivating enzyme, GTPase-activating protein (GAP), which stim-
ulates the GTPase activity of Rab32/38. Although BLOC-3 has
already been identified as a Rab32/38-specific GEF that regu-
lates the trafficking of tyrosinase and Tyrp1, no physiological
GAP for Rab32/38 in melanocytes has ever been identified, and
it has remained unclear whether Rab32/38 is involved in the
trafficking of dopachrome tautomerase, another melanogenic
enzyme, in mouse melanocytes. In this study we investigated
RUTBC1, which was originally characterized as a Rab9-binding
protein and GAP for Rab32 and Rab33B in vitro, and the results
demonstrated that RUTBC1 functions as a physiological GAP
for Rab32/38 in the trafficking of all threemelanogenic enzymes
in mouse melanocytes. The results of this study also demon-
strated the involvement of Rab9A in the regulation of the
RUTBC1 localization and in the trafficking of all three melano-
genic enzymes. We discovered that either excess activation or
inactivation of Rab32/38 achieved by manipulating RUTBC1
inhibits the trafficking of all three melanogenic enzymes. These
results collectively indicate that proper spatiotemporal regula-
tion of Rab32/38 is essential for the trafficking of all three mel-
anogenic enzymes in mouse melanocytes.
Mammalian epidermalmelanocytes are specialized cells that
produce the pigment melanin, which is synthesized and stored
in specialized organelles called melanosomes. Melanosomes
have several features in common with lysosomes, but because
melanosomes possess other specific characteristics of their
own, such as containing the melanogenic enzymes that are
responsible for melanin synthesis, i.e. tyrosinase, tyrosinase-
related protein 1 (Tyrp1),3 and dopachrome tautomerase (Dct),
they are generally considered to be lysosome-related organelles
(1, 2). Tyrosinase and Tyrp1 clearly have been demonstrated to
be transported from the trans-Golgi network by way of endo-
somes into immature premelanosomes, away from degrada-
tive lysosomes (1). By contrast, relatively little is known
about the transport of Dct, although, to our knowledge, one
study has shown that Dct is transported directly from the
trans-Golgi network to immature malanosomes (3). Defects
in the trafficking of these melanogenic enzymes have been
shown to cause a number of pigment disorders, including
Hermansky-Pudlak syndrome (HPS), which is characterized
by prolonged bleeding, immunodeficiency, and pulmonary
fibrosis as well as hypopigmentation of the hair, skin, and
eyes (4, 5). The genes responsible for HPS encode the sub-
units of five large cytoplasmic complexes, i.e. adaptor pro-
tein complex-3 (AP-3), vacuolar protein sorting (VPS)-C,
and biogenesis of lysosome-related organelles complex
(BLOC)-1, BLOC-2, and BLOC-3 (4, 5).
Rab proteins are small GTPases that are well recognized as
membrane-trafficking regulators in all eukaryotes (6–8). They
function as switch molecules that cycle between a GDP-bound
inactive formandGTP-bound active form,which interactswith
effector molecules to promote membrane trafficking events
(6–8). Two regulatory enzymes, a guanine nucleotide ex-
change factor (GEF) and a GTPase-activating protein (GAP),
control the spatiotemporal Rab cycle by activating and inacti-
vating, respectively, the Rab proteins (9, 10). The discovery of
dramatically lower levels of tyrosinase and Tyrp1 in Rab32
knockdown melan-cht cells (mutation in the Rab38 locus) has
revealed that Rab32 and Rab38 redundantly regulate the traf-
ficking of melanogenic enzymes, at least of tyrosinase and
Tyrp1 (11). Interestingly, however, Rab32, and not Rab38, has
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recently been reported responsible for the trafficking of Dct in
human MNT-1 melanoma cells, suggesting the existence of
trafficking pathways for tyrosinase/Tyrp1 and Dct in human
melanoma cells (3). A physiological GEF and an effector mole-
cule of Rab32/38 have already been identified in melanocytes.
BLOC-3, a heterodimer of HPS1 and HPS4, functions as a
Rab32/38 GEF (12), and mutations of either of these subunits
are known to cause HPS (13). The VPS9-ankyrin repeat protein
(Varp; official name is Ankrd27) is a Rab32/38 effector that
regulates the trafficking of tyrosinase andTyrp1 inmelanocytes
(14–16). Moreover, BLOC-2 has been reported to be an effec-
tor molecule complex of Rab32/Rab38 (3) with the function of
targeting recycling endosomal intermediates containing the
melanogenic enzymes to melanosomes (17). Nevertheless, no
physiological GAP for Rab32/38 has ever been identified in
melanocytes, although a Rab9-binding protein, RUTBC1, has
recently been reported to possess in vitro GAP activity toward
Rab32 and Rab33B (18, 19).
In this study we investigated the physiological function of
RUTBC1 in melanogenic enzyme trafficking in mouse melano-
cytes. The results showed that RUTBC1 is a physiologicalGAP for
Rab32/38 in melanocytes and that either excess activation of
Rab32/38 or inactivation of Rab32/38, achieved by manipulating
RUTBC1, inhibited the trafficking of all threemelanogenic enzymes.
FIGURE 1. Effect of overexpression of RUTBC1 on themelanosomal localization ofmelanogenic enzymes inmelanocytes.A, schematic representation of the
human RUTBC1 and its truncated mutants (RUTBC1-N and RUTBC1-C) used in this study. RUTBC1 contains an N-terminal RUN domain (light gray boxes), which
possesses Rab9A/B binding activity, and a C-terminal TBC domain (dark gray boxes), which exhibits GAP activity toward Rab32 and Rab33B in vitro (18, 19). R803A
mutants lack a catalytic Arg residue that is crucial for GAP activity (31). B, typical images ofmelanocytes expressing T7-RUTBC1, T7-RUTBC1(R803A), T7-RUTBC1-N, or
T7-GFP (as a negative control).Melan-a cellswere transfectedwith each T7-taggedprotein-expressingplasmid and stainedwith anti-tyrosinase antibody, anti-Tyrp1
antibody, or anti-Dct antibody. Cells expressing T7-tagged protein are outlined with a broken line. Scale bars, 20 m. C, quantification of the tyrosinase/Tyrp1/Dct
signalsshowninB. Thebars representthemeansofthedata(n20).Thesymbolsrepresenttherelative intensityof thetyrosinase/Tyrp1/Dctsignals incellsexpressing
T7-GFP (squares), T7-RUTBC1 (triangles), T7-RUTBC1(R803A) (inverted triangles), and T7-RUTBC1-N (diamonds). **, p 0.01, Dunnett’s test.
Rab32/38 Inactivation by RUTBC1 inMelanocytes
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Based on our findings we discuss the possiblemolecularmechanism
responsible for the spatiotemporal regulation of Rab32/38 by
RUTBC1 and its binding partner, Rab9A, inmelanocytes.
Experimental Procedures
Materials—The following antibodies used in this study were
obtained commercially: anti-GFP rabbit polyclonal antibody
(MBL, Nagoya, Japan); anti-FLAG tag rabbit polyclonal anti-
body, anti-FLAG tag mouse monoclonal (M2) antibody, and
anti-FLAG tag antibody-conjugated agarose beads (Sigma-Al-
drich); horseradish peroxidase (HRP)-conjugated anti-T7 tag
mouse monoclonal antibody and anti-T7 tag antibody-conju-
gated agarose beads (NovagenTM, Merck, Darmstadt, Germany);
anti-HA tag rat monoclonal (3F10) antibody (Roche Diagnos-
FIGURE 2.TheGAPactivity of theC-terminal TBCdomainof RUTBC1 is involved in tyrosinase/Tyrp1/Dct trafficking inmelanocytes.A–E, typical images
ofmelanocytes expressingT7-GFP, T7-RUTBC1-C, or T7-RUTBC1-C(R803A).Melan-a cellswere transfectedwitheachT7-taggedprotein-expressingplasmidand
stainedwithantibodies against tyrosinase (A), Tyrp1 (B), Dct (C), Rab32 (D), or Rab38 (E). Cells expressingT7-taggedproteins areoutlinedwithabroken line.Scale
bars, 20m. F, quantification of the tyrosinase/Tyrp1/Dct/Rab32/Rab38 signals shown in A–E. The bars represent themeans of the data (n 20). The symbols
represent the relative intensity of the tyrosinase/Tyrp1/Dct/Rab32/Rab38 signals in cells expressing T7-GFP (squares), T7-RUTBC1-C (triangles), and
T7-RUTBC1(R803A)-C (inverted triangles). *, p 0.05; **, p 0.01, Dunnett’s test. NS, not significant.
Rab32/38 Inactivation by RUTBC1 inMelanocytes
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tics); anti--actin mouse monoclonal antibody (Applied Bio-
logical Materials, Richmond, British Columbia, Canada); HRP-
conjugated anti-GST rabbit polyclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, CA); andAlexa Fluor 488/594-con-
jugated anti-mouse/rabbit IgG goat antibody (Invitrogen). Rab-
bit polyclonal antibodies against Rab32, Rab38, tyrosinase, and
Tyrp1 were prepared as described previously (14, 20, 21). Anti-
Dct rabbit polyclonal antibody was raised against a peptide cor-
responding to the C-terminal sequence (amino acid residues
504–517) of mouse Dct and affinity-purified essentially as
described previously (21). Anti-Rab9A rabbit polyclonal anti-
body was produced by using purified GST-tagged mouse
Rab9A (22). Glutathione-Sepharose beads were purchased
from GE Healthcare.
Plasmid Construction—cDNA encoding the open reading
frame of human RUTBC1 was amplified from an RUTBC1/
KIAA0397 clone (Kazusa DNA Research Institute, Chiba,
Japan) by PCR, performed with specific primers containing a
BglII linker (underlined) or a stop codon (bold) plus a SalI linker
(underlined) as follows:Met primer, 5-GGGGAGATCTATG-
GGCAGCGCAGAGGACGC-3; and stop primer, 5-GGGG-
GTCGACTCACTTGTTCTCTATGAGCA-3. cDNA encod-
ing the open reading frame of mouse HPS4 was amplified from
Marathon-Ready adult mouse brain/testis cDNA (Clontech-
Takara Bio, Shiga, Japan) by PCR using specific primers con-
taining a BamHI linker (underlined) or a stop codon (bold) as
follows: Met primer, 5-GGATCCATGGCCACCACCACTC-
CCCC-3; and stop primer, 5-TCACAGCAGGTTTACCC-
CGT-3. The purified PCR products were subcloned into the
pGEM-T Easy vector (Promega, Madison, WI). The cDNA
inserts were excised with the appropriate restriction enzymes
and subcloned into the pEF-T7 tag, pEF-HA tag, or pEF-T7-
GST tagmammalian expression vector or the pEGFP-C1 vector
(Clontech-Takara Bio) as described previously (23, 24). An
RUTBC1 mutant carrying an Arg-to-Ala mutation at amino
acid position 803 (R803A) was prepared by conventional PCR
techniques performed with mutagenic oligonucleotides as
described previously (25). Truncatedmutants of RUTBC1 (Fig.
1A) were also prepared by conventional PCR techniques per-
formed with specific pairs of oligonucleotides. pEF-T7-GST-
Varp was constructed by transferring the cDNA insert of pEF-
T7-Varp-ANKR1 (amino acid residues 451–729) (14) into the
pEF-T7-GST vector (referred to as pEF-T7-GST-Varp in this
article). pEF-FLAG-Rab32, pEF-FLAG-Rab32(Q83L), pEF-
FLAG-Rab38, and pEF-FLAG-Rab38 (Q69L) were prepared as
described previously (26, 27).
RNAi—The siRNAs against mouse RUTBC1 (target site 1,
5-CCAGGAAATTCGTGCATGA-3; and target site 2, 5-
GCAGCCACATCATTGCTCT-3), mouse Rab9A (target site,
5-CAAGACTGACATAAAAGAA-3), andmouseRab38 (tar-
get site, 5-CAATGGACTCAAGATGGAC-3) were chemi-
cally synthesized byNipponGene (Toyama, Japan). The siRNA
against mouse Rab32 has been described previously (15). The
Stealth RNAiTM siRNAs against mouse Varp were obtained
from Invitrogen (catalogue No. MSS217316).
RT-PCR—The total RNA of melan-a cells transfected with
RUTBC1 siRNA and control siRNA were prepared with TRI
Reagent (Sigma-Aldrich), and reverse transcription was per-
formed by using ReverTra Ace (Toyobo, Osaka, Japan)
according to the manufacturer’s instructions. The following
pairs of oligonucleotideswere used for amplification: formouse
RUTBC1, forward primer, 5-GCATCCAGTCCAGCCTAGAT-
3, and reverse primer, 5-GCAGGAACCAGCGATAACAG-
3; and forGAPDH, forward primer, 5-ATGGTGAAGGTCG-
GAGTCAA-3, and reverse primer, 5-GCCATGTAGAC-
CATGAGGTC-3. The cDNAs of RUTBC1 and GAPDH were
amplified by PCR performed with Ex-Taq DNA polymerase
(Clontech-Takara Bio).
Immunofluorescence Analysis—The black mouse-derived
immortal melanocyte cell line melan-a (generous gift of Doro-
thy C. Bennett) was cultured as described previously (28, 29).
Plasmids were transfected into melan-a cells for 48 h using
Lipofectamine 2000 (Invitrogen) according to the manufactu-
rer’s instructions. After transfection, the cells were fixed with
10% (w/v) trichloroacetic acid, permeabilized with 0.1% Triton
X-100, stained with specific primary antibodies, and then visu-
alized with Alexa Fluor 488/594-conjugated secondary anti-
bodies. The stained cells were examined for fluorescence with a
confocal fluorescence microscope (FluoView 1000-D, Olym-
pus, Tokyo, Japan) through an objective lens (60 magnifica-
tion, N.A. 1.40, Olympus) and with FluoView software (version
4.1a, Olympus). The images were processed with Adobe Pho-
toshop software (CS5). The fluorescent signals of the melano-
genic enzymes and Rab32/38were captured at random (20 cells
each) with the confocal microscope and quantified with Meta-
Morph software (Molecular Devices, Sunnyvale, CA). The sta-
FIGURE 3. Both Rab32 and Rab38 are present in the cytosolic fraction of
RUTBC1-expressing melanocytes. A and B, B16-F1 cells expressing FLAG-
Rab32 (A) or FLAG-Rab38 (B) together with T7-GFP, T7-RUTBC1, or T7-
RUTBC1(R803A) (RA) were homogenized, and the soluble and membrane
fractions were separated as described under “Experimental Procedures.”
Note that the amount of FLAG-Rab32/38 in the soluble fraction was greatly
increased in the RUTBC1-expressing cells when compared with the GFP-ex-
pressing cells or RUTBC1(R803A)-expressing cells. The positions of themolec-
ular mass markers (in kDa) are shown on the left.
Rab32/38 Inactivation by RUTBC1 inMelanocytes
1430 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 3•JANUARY 15, 2016
 at TSU
K
U
BA
 D
A
IG
A
K
U
 on January 20, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tistical analyses were performed using Dunnett’s test or
Student’s unpaired t test, and p values 0.05 were considered
statistically significant.
Co-immunoprecipitation andGSTPulldownAssays—COS-7
cells were transfected for 36 h with pEF-T7-GST-Varp or pEF-
T7-GST by using Lipofectamine-LTX Plus (Invitrogen). The
transfected cells were lysed with lysis buffer (50 mM HEPES-
KOH, pH 7.2, 150mMNaCl, 1mMMgCl2, and 1%Triton X-100
supplemented with complete EDTA-free protease inhibitor
mixture (Roche)), and the cell lysates were incubated for 2 h at
4 °Cwith glutathione-Sepharose beads. The beadswerewashed
three times with washing buffer (50 mM HEPES-KOH, pH 7.2,
150mMNaCl, 1mMMgCl2, and 0.2%TritonX-100), andCOS-7
cell extracts that had been co-transfected with pEF-T7-
RUTBC1 wild-type (WT)/R803A and pEF-FLAG-Rab32/38
were incubated with the glutathione-Sepharose beads coupled
with T7-GST-Varp or T7-GST.
COS-7 cell extracts that had been transfected with pEF-T7-
Varp were lysed with the lysis buffer and allowed to react with
anti-T7 tag antibody-conjugated agarose beads for 2 h at 4 °C.
The beadswerewashed three timeswith thewashing buffer and
then incubated for 2 h at 4 °C with the lysates from RUTBC1
knockdownmelan-a cells or controlmelan-a cells. The proteins
bound to the beads were analyzed by 10% SDS-PAGE followed
by immunoblotting with the indicated antibodies.
Subcellular Fractionation—B16-F1 melanoma cells that had
been transfected with pEF-FLAG-Rab32/38 together with pEF-
T7-RUTBC1(WT/R803A) or pEF-T7-GFP were harvested and
homogenized in 0.32 M sucrose, 5 mM HEPES-KOH, pH 7.2, 1
mM EGTA, 1 mM -mercaptoethanol, and complete EDTA-
free protease inhibitor mixture (Roche) in a glass-Teflon Potter
homogenizer as described previously (21). The homogenate
was centrifuged at 1000 g for 10 min at 4 °C; then the super-
natant was centrifuged at 100,000  g for 1 h at 4 °C, and the
supernatant and precipitate obtainedwere used as the cytosolic
fraction and the membrane fraction, respectively. Equal pro-
portions of the cytosolic fraction and membrane fraction were
subjected to 10 or 7.5% SDS-PAGE and analyzed by
immunoblotting.
Results
Functional Involvement of RUTBC1 in Melanogenic Enzyme
Trafficking in Melanocytes—It had been demonstrated previ-
ously that Rab32 and Rab38 redundantly regulate the traffick-
ing of tyrosinase and Tyrp1 to melanosomes and that knock-
down of either Rab isoform alone in melanocytes has no effect
FIGURE4.RUTBC1inactivatesbothRab32andRab38inlivingcells.A,COS-7cellsexpressingFLAG-Rab32togetherwithT7-GFP,T7-RUTBC1,orT7-RUTBC1(R803A)
(RA) were lysed, and theGTP-bound active Rab32was pulled downwith glutathione-Sepharose beads that had been coupledwith T7-GST (as a negative control) or
T7-GST-Varp, which contains the Rab32/38-binding region of Varp. B, COS-7 cells expressing FLAG-Rab38 together with T7-GFP, T7-RUTBC1, or T7-RUTBC1(R803A)
were lysed, and theGTP-bound active Rab38was pulled down in the sameway as described inA. Note that RUTBC1, but not its R803Amutant, dramatically reduced
the amount of GTP-Rab32 andGTP-Rab38 (compare lanes 5 and 6 in the second panel from the top inA and B, respectively). Input, 0.8%of the volumeof the reaction
mixture (top and third panels).Arrowheads indicate the positions of T7-tagged and T7-GST-taggedproteins. The positions of themolecularmassmarkers (in kDa) are
shown on the left.
Rab32/38 Inactivation by RUTBC1 inMelanocytes
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on themelanosomal localization of either of thesemelanogenic
enzymes (3, 11, 15). Because a Tre-2/Bub2/Cdc16 (TBC)
domain-containing protein, RUTBC1, has been shown to pos-
sess GAP activity toward Rab32 but with roughly 10-fold lower
activity toward Rab38 in vitro (18), overexpression of RUTBC1
in melanocytes was expected to have no or little effect on the
expression of tyrosinase and Tyrp1, the same as in Rab32 sin-
gle knockdown cells (3, 11). Surprisingly, however, when
T7-tagged RUTBC1 was expressed in melan-a cells, the results
of an immunofluorescence analysis showed that it had strongly
reduced expression of all three melanogenic enzymes, tyrosin-
ase, Tyrp1, and Dct (Fig. 1B, top two rows, and C). As demon-
strated previously by us and other groups (3, 16, 30), defects in
the trafficking of melanogenic enzymes usually cause loss of
their expression, mainly as a result of lysosomal degradation,
because melanogenic enzymes that are not properly trans-
ported to melanosomes are redirected to lysosomes for degra-
dation. Actually, when RUTBC1-overexpressing melanocytes
were treated with bafilomycin A1, a V-ATPase inhibitor that
blocks lysosomal degradation, tyrosinase signals were clearly
recovered, consistent with findings in the previous studies
(3, 16, 30) (data not shown). To determine whether the reduc-
tion in tyrosinase/Tyrp1/Dct signals was attributable to the
GAP activity of the RUTBC1 TBC domain, we prepared two
truncatedmutants lacking anN-terminal RUN domain, named
T7-RUTBC1-C and T7-RUTBC1-C(R803A), the latter of
which lacks a catalytic Arg residue for the GAP activity of TBC
proteins (Fig. 1A) (31). As shown in Fig. 2, A–C and F,
RUTBC1-C reduced the expression of all three melanogenic
enzymes, whereas RUTBC1-C(R803A) did not. These results
indicated that the reduction in tyrosinase/Tyrp1/Dct signals in
RUTBC1-C-expressing melanocytes are likely attributable to
the forced inactivation of substrate Rab proteins of RUTBC1.
Unexpectedly, however, overexpression of the full-length
RUTBC1(R803A) mutant still reduced the tyrosinase/Tyrp1/
Dct signals (Fig. 1, B and C), suggesting the existence of an
FIGURE5.Rab32/38andVarp regulate the traffickingof all threemelanogenic enzymes.A, typical images of Rab32 knockdownand/or Rab38 knockdown
melanocytes (tyrosinase, Tyrp1, andDct images).Melan-a cellswere transfectedwith siRNAs against Rab32 and/or Rab38 and then stainedwith anti-tyrosinase
antibody, anti-Tyrp1antibody, or anti-Dct antibody. Scale bars, 20m.B, reducedexpressionof all threemelanogenic enzymes inRab32/38double knockdown
melanocytes as revealed by immunoblotting with the antibodies indicated. C, typical images of Varp knockdown melanocytes (tyrosinase, Tyrp1, and Dct
images). Melan-a cells were transfected with Stealth RNAiTM siRNAs against Varp and then stained with the indicated antibodies. Scale bars, 20 m. Cells
exhibiting reduced melanogenic enzyme signals are outlined with a broken line in A and C. D, reduced expression of all three melanogenic enzymes in Varp
knockdownmelanocytes as revealedby immunoblottingwith the antibodies indicated. Thepositions of themolecularmassmarkers (in kDa) are shownon the
left in B and D.
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additional GAP activity-independent mechanism that presum-
ably is mediated by the N-terminal half of RUTBC1 (for details,
see the last two paragraphs under “Results”).
RUTBC1 Possesses GAP Activity toward Both Rab32 and
Rab38—The inhibitory effect of the RUTBC1 overexpression
on the trafficking of all three melanogenic enzymes led us to
hypothesize that in living cells RUTBC1 possesses GAP activity
toward Rab32 and Rab38, both of which redundantly regulate
the trafficking of tyrosinase andTyrp1 (3, 11, 14, 15). To test our
hypothesis, we investigated the endogenous Rab32/38 expres-
sion in T7-RUTBC1-C-expressing cells by performing immu-
nostaining. Intriguingly, T7-RUTBC1-C dramatically reduced
both the Rab32 signals and the Rab38 signals in melan-a cells,
whereas T7-RUTBC1-C(R803A) had no effect (Fig. 2, D–F).
Because GDP-Rab proteins are generally thought to be present
in the cytosol and to be lost during permeabilization with Tri-
ton X-100, we hypothesized that the reduced Rab32/38 signals
in RUTBC1-expressing cells were attributable to the increased
level of the GDP-bound form of Rab32/38. To test this hypoth-
esis, we performed a subcellular fractionation experiment with
B16-F1melanoma cells that had been transfectedwith a FLAG-
Rab32/38 expression vector together with a T7-RUTBC1(WT/
R803A) expression vector. As anticipated, the results showed
that both Rab32 and Rab38 were present in the cytosolic frac-
tion of RUTBC1(WT)-overexpressing cells rather than in their
membrane fraction, whereas they were present mainly in the
membrane fraction in the control GFP-expressing cells and
RUTBC1(R803A)-expressing cells (Fig. 3). Thus, the reduced
Rab32 and Rab38 signals in RUTBC1(WT)-overexpressing
cells shown in Fig. 2 are likely attributable mainly to the loss of
GDP-Rab32/38 from the cells during the permeabilization
process.
To confirm the GAP activity of RUTBC1 toward Rab32/38
biochemically, we proceeded to perform GTP-Rab32/38 pull-
down assays by using a specificGTP-Rab32/38-binding domain
of Varp (14). In brief, we coexpressed T7-RUTBC1(WT/
R803A) and FLAG-Rab32/38 in cultured mammalian cells and
then incubated their lysates with GST-tagged Varp, a spe-
cific GTP-Rab32/38 trapper. As anticipated, the amount of
GTP-Rab32/38 was dramatically decreased when FLAG-
Rab32/38 were coexpressed with T7-RUTBC1 (Fig. 4, A
and B, lane 5, second panel from top), whereas
T7-RUTBC1(R803A) failed to reduce the amount of GTP-
Rab32/38 at all (Fig. 4, A and B, lane 6, second panel from top).
Taken together, these results allowed us to conclude that
RUTBC1 possesses GAP activity toward both Rab32 and Rab38
in living cells, even though RUTBC1 had been found to exhibit
much lower Rab38-GAP activity in vitro (18).
Rab32 and Rab38 Regulate the Trafficking of All Three
Melanogenic Enzymes in Melanocytes—Because it has been
reported previously that Rab32 is involved specifically, and
Rab38 is not involved, in the trafficking of Dct to melanosomes
in human MNT-1 cells (3), and because RUTBC1 inhibits Dct
trafficking to melanosomes (Fig. 1), we reinvestigated the
involvement of Rab32/38 in the trafficking of tyrosinase/Tyrp1/
Dct inmousemelan-a cells.We did so by using specific siRNAs
to knock down Rab32 alone, Rab38 alone, or both Rab32 and
Rab38 in melan-a cells. Knockdown of either Rab32 or Rab38
alone in the melan-a cells did not alter the signals of the three
melanogenic enzymes at all, whereas double knockdown of
Rab32/38 dramatically reduced the signals of tyrosinase/
Tyrp1/Dct according to the results obtained from both immu-
nostaining (Fig. 5A) and immunoblotting (Fig. 5B). Consistent
with these results, the knockdown of Varp, a Rab32/38 effector
(14, 15), in melan-a cells also resulted in a reduction of Dct
signals as well as tyrosinase/Tyrp1 signals according to both the
immunostaining (Fig. 5C) and the immunoblotting (Fig. 5D)
findings. These results indicate that Rab32/38 and Varp are
FIGURE 6. RUTBC1 knockdown inmelanocytes reduces the expression of all threemelanogenic enzymes. A, knockdown efficiency of RUTBC1 siRNAs in
melanocytes as revealed by RT-PCR analysis (top two panels) and in COS-7 cells as revealed by immunoblotting (bottom two panels). Both RUTBC1 siRNAs (st1
and st2) efficiently suppressed expression of RUTBC1 mRNA (upper top panel) and EGFP-RUTBC1 protein (upper bottom panel). GAPDH mRNA expression is
shown as a control to ensure that equivalent amounts of first-strand cDNAwere used for the RT-PCR analysis. The size of themolecular weightmarkers (in bp,
top two panels) is shown on the left side of these panels. B, RUTBC1 knockdown dramatically suppressed the expression of all three melanogenic enzymes in
melanocytes without altering the expression of Rab32/38. The positions of themolecular massmarkers (in kDa) are shown on the left in A (bottom two panels)
and B. C, typical images of RUTBC1 knockdownmelanocytes stained with the indicated antibodies. Scale bars, 20 m.
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required for proper trafficking of all three melanogenic
enzymes, at least in mouse melanocytes.
Excess Activation of Rab32 and Rab38 Caused Inhibition of
Melanogenic Enzyme Trafficking—Next, we investigated the
function of endogenous RUTBC1 in melanocytes by knocking
down RUTBC1 with specific siRNAs. First, we demonstrated
endogenous expression of RUTBC1 by performing an RT-PCR
analysis and validated the knockdown efficacy of two indepen-
dentRUTBC1 siRNAs inmelan-a cells (Fig. 6A). If RUTBC1 is a
crucial factor for inactivating Rab32/38 during melanogenic
enzyme trafficking, RUTBC1 knockdown should result in
reduced Rab32/38 inactivation, i.e. an increase in GTP-
Rab32/38 level, and it affectsmelanogenic enzyme trafficking in
the RUTBC1 knockdown cells. As anticipated, the level of
endogenous GTP-Rab32/38 that co-immunoprecipitated with
T7-Varp was higher in the RUTBC1 knockdown melan-a cells,
but there was no change in the total level of Rab32/38 expres-
sion (Fig. 7C). Moreover, immunostaining clearly revealed
greater melanosomal Rab32/38 signals in the RUTBC1 knock-
down melan-a cells (Fig. 7, A and B), suggesting that Rab32/38
were excessively activated and continuously localized on mela-
nosomalmembranes in theRUTBC1knockdownmelan-a cells.
Because activation of Rab32/38 is essential for the trafficking
of tyrosinase/Tyrp1/Dct (3, 11, 12, 15) (Fig. 5), we initially
thought that RUTBC1 knockdown, i.e. an increase in the GTP-
Rab32/38 level, would increase the level of expression of all
three melanogenic enzymes. Unexpectedly, however, the sig-
nals of all three melanogenic enzymes were dramatically
reduced in the RUTBC1 knockdownmelan-a cells (Fig. 6,B and
C), despite the excess activation of Rab32/38 (Fig. 7C). To
investigate the effect of excess activation of Rab32/38 on mela-
nogenic enzyme trafficking by a different approach, we
expressed a constitutively active mutant of Rab32(Q83L) or
Rab38(Q69L) in melan-a cells and quantified the intensity of
FIGURE 7. RUTBC1 knockdown increases the melanosomal expression of Rab32/38. A and B, typical images of RUTBC1 knockdownmelanocytes stained
with anti-Rab32 antibody (A) or anti-Rab38 antibody (B) and their corresponding bright field images. The insets showmagnified views of the boxed areas. Note
that only a few Rab32/38-positive signals colocalized with melanosomes (Mel, pseudo-colored in red) in the control siRNA-treated melanocytes, whereas the
melanosomal Rab32/38 signals were clearly increased in the RUTBC1 knockdownmelanocytes. Scale bars, 20m. C, excess activation of Rab32/38 in RUTBC1
knockdown melanocytes as revealed by immunoblotting with the indicated antibodies. Anti-T7 tag antibody-conjugated agarose beads that had been
coupled with T7-GFP or T7-Varp (ANKR1, an active Rab32/38 trapper) were incubated with the lysates of RUTBC1 knockdown melanocytes. Immunoprecipi-
tated T7-GFP or T7-Varp and co-immunoprecipitated endogenous Rab32/38 were detected with the antibodies indicated. Input, 1% of the volume of the
reaction mixture (two panels on the left). The positions of the molecular mass markers (in kDa) are shown on the left.
Rab32/38 Inactivation by RUTBC1 inMelanocytes
1434 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 3•JANUARY 15, 2016
 at TSU
K
U
BA
 D
A
IG
A
K
U
 on January 20, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
the tyrosinase/Tyrp1/Dct signals. Although expression of wild-
type Rab32/38 in melan-a cells had no significant effect on the
tyrosinase/Tyrp1/Dct signals, expression of Rab32(Q83L) or
Rab38(Q69L) dramatically reduced their signals (Fig. 8), the
same as knockdown of Rab32/38 or Varp did (Fig. 5).
Functional Involvement of Rab9A in Melanogenic Enzyme
Trafficking—Finally, we attempted to determine the molecular
basis for the reduction in expression of all three melanogenic
enzymes as a result of overexpression of the GAP activity-defi-
cient T7-RUTBC1(R803A) mutant, the same as occurred in
response to overexpression of the wild-type T7-RUTBC1 (Fig.
1, B and C). As T7-RUTBC1-C(R803A) did not exert an inhib-
itory effect (Fig. 2), theN-terminal half of RUTBC1, which con-
tains a RUN domain, is very likely to have an additional role in
melanogenic enzyme trafficking. Interestingly, RUTBC1 has
also been identified as a Rab9 effector, and the N-terminal half
of RUTBC1 has been shown to be responsible for Rab9 binding
(18, 19). We therefore turned our attention to Rab9 and inves-
tigated its involvement in the trafficking of tyrosinase/Tyrp1/
Dct in melan-a cells. Because melan-a cells express only the
Rab9A isoform and do not express the Rab9B isoform (data not
shown), we expressed Rab9A together with RUTBC1(WT/
R803A) in melan-a cells. As shown in Fig. 9A (left panels),
Rab9A and RUTBC1(WT/R803A) were often co-localized at
melanosomes. This melanosomal localization of RUTBC1 pre-
sumably is mediated by Rab9A, because most RUTBC1 itself
appears to be present in the cytoplasm (Fig. 9A, right panels).
Intriguingly, melan-a cells expressing both RUTBC1 and
Rab9A contained dramatically reduced tyrosinase signals,
whereas expression of both RUTBC1(R803A) and Rab9A or
Rab9A alone had no effect on tyrosinase signals (Fig. 9A, left
panels, and B). We also knocked down endogenous Rab9A by
using a specific siRNA, and the results show dramatic reduc-
tions in the expression of all three melanogenic enzymes (Fig.
10).
Finally, to investigate the functional relationship between
Rab9 and RUTBC1, we focused on HPS4, a subunit of a
Rab32/38GEF, BLOC-3 (12), becauseHPS4 is also known to be
a Rab9 effectormolecule (32). Consistent with previous reports
(18, 19, 32), we confirmed the existence of HPS4-Rab9A and
RUTBC1-Rab9A interactions (Fig. 11, lane 4, second panel
from top, and lane 5, top panel). We then performed a compe-
tition experiment and found that RUTBC1 expression is able to
disrupt the interaction between Rab9A and HPS4 (Fig. 11, lane
6, second panel from top). These results indicated that overex-
pression of RUTBC1 has at least two impacts: direct inactiva-
FIGURE 8.Overexpression of a constitutively active formof Rab32/38 inmelanocytes reduces the expression of all threemelanogenic enzymes. A–C,
typical images of melanocytes expressing FLAG-Rab32(WT/Q83L) (tyrosinase, Tyrp1, and Dct images). Melan-a cells were transfected with pEF-FLAG-
Rab32(WT/Q83L) and then stained with the indicated antibodies. Cells expressing FLAG-tagged protein are outlined with broken lines. Scale bars, 20m.D–F,
typical images of melanocytes expressing FLAG-Rab38(WT/Q69L) (tyrosinase, Tyrp1, and Dct images). G–I, quantification of the tyrosinase/Tyrp1/Dct signals
shown in A–F. The bars represent the means of the data (n  20). The symbols represent the relative intensity of the tyrosinase/Tyrp1/Dct signals in cells
expressingFLAG-GFP (squares), FLAG-Rab32 (triangles), FLAG-Rab32(Q83L) (inverted triangles), FLAG-Rab38 (diamonds), andFLAG-Rab38(Q69L) (circles). **,p
0.01, Dunnett’s test.
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tion of Rab32/38 by its TBC/Rab-GAP domain and indirect inac-
tivation of Rab32/38 by disrupting a complex composed of Rab9
and BLOC-3 (see Discussion below). All these results taken
together indicated that spatiotemporal regulation of Rab32/38 by
RUTBC1 and a RUTBC1 binding partner, Rab9A, is involved in
the trafficking of melanogenic enzymes inmelanocytes.
FIGURE 9. Rab9A is involved in the proper trafficking of tyrosinase to melanosomes. A, typical images of melanocytes expressing FLAG-Rab9A together with
T7-RUTBC1or T7-RUTBC1(R803A), FLAG-Rab9Aalone, or T7-RUTBC1alone. The cellswere stainedwithanti-T7/anti-FLAGantibodies, anti-T7/anti-tyrosinaseantibod-
ies, or anti-FLAG/anti-tyrosinase antibodies, and their corresponding bright field (BF) images are shown. Cells expressing T7-RUTBC1(WT/R803A) or FLAG-Rab9A are
outlinedwithbroken lines. The insets showmagnified viewsof theboxed areas. Scale bars, 20m.Note that the tyrosinase signalsweredecreased in themelanocytes
expressing T7-RUTBC1/FLAG-Rab9A but not in the melanocytes expressing T7-RUTBC1(R803A)/FLAG-Rab9A. B, quantification of the tyrosinase signals shown in A.
The bars represent the means of the data (n 20). The symbols represent the relative intensity of the tyrosinase/Tyrp1/Dct signals in cells expressing FLAG-Rab9A
(squares), FLAG-Rab9A/T7-RUTBC1 (triangles), and FLAG-Rab9A/T7-RUTBC1(R803A) (inverted triangles). *, p 0.05, Dunnett’s test.NS, not significant.
FIGURE10.Rab9A is involved in theproper traffickingofall threemelanogenicenzymes tomelanosomes.A, typical imagesofRab9Aknockdownmelanocytes
stainedwith anti-tyrosinase antibody, anti-Tyrp1 antibody, and anti-Dct antibody. Scale bars, 20m. B, quantificationof the tyrosinase/Tyrp1/Dct signals shown inA.
Thebars represent themeansof thedata (n20). The symbols represent the relative intensityof the tyrosinase/Tyrp1/Dct signals in control cells (squares) andRab9A
knockdown cells (triangles). **, p 0.01, Student’s unpaired t test. C, reduced expression of all three melanogenic enzymes in Rab9A knockdown melanocytes as
revealed by immunoblottingwith the indicated antibodies. The positions of themolecularmassmarkers (in kDa) are shown on the left.
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Discussion
Although RUTBC1 had been reported to possess GAP activ-
ity toward Rab32 and Rab33B, but roughly 10-fold lower activ-
ity toward Rab38, in vitro (18), its physiological function had
remained unknown. In this paper we have presented several
lines of evidence that RUTBC1 is a physiological GAP for
Rab32/38 that is crucial for melanogenic enzyme transport to
melanosomes in melanocytes. The first line of evidence is that
overexpression of the C-terminal TBC/Rab-GAP domain of
RUTBC1, but not overexpression of its catalytic Arg mutant
(R803A), in melanocytes induced a dramatic reduction in the
amount of melanogenic enzymes (tyrosinase/Tyrp1) (Fig. 2, A
and B). Similarly, double knockdown of Rab32/38 in melano-
cytes induced the same phenotype, whereas single knockdown
of Rab32 or Rab38 alone had no effect on tyrosinase/Tyrp1
signals (Fig. 5, A and B). The second line of evidence is that
decreasedRab32/38 signalswere observed inRUTBC1-C-over-
expressing melan-a cells (Fig. 2, D and E) and increased
Rab32/38 signals were observed in RUTBC1 knockdown
melan-a cells (Fig. 7, A and B). The final line of evidence is that
RUTBC1, but not RUTBC1(R803A), dramatically decreased
the amount ofGTP-Rab38 aswell asGTP-Rab32 inCOS-7 cells
(Fig. 4) and that the amount of GTP-Rab32/38 was increased in
RUTBC1 knockdown melan-a cells (Fig. 7C). These findings
allowed us to conclude that RUTBC1 is a functional Rab32/38
GAP inmelanocytes.Nottingham et al. (18), however, report find-
ing that RUTBC1 exhibits roughly 10-fold lower Rab38-GAP
activity than Rab32-GAP activity in vitro. Although the reason for
the discrepancy between their findings and our own is unknown,
this lower in vitro Rab38-GAP activity of RUTBC1 may be suffi-
cient to inactivate endogenous Rab38 in living cells. Alternatively,
the recombinant Rab38 protein purified from bacteria (18) that
they used may not fold correctly and consequently may fail to
function as an efficient substrate of RUTBC1.
Because both overexpression and knockdown of RUTBC1
induced a dramatic reduction in the amount of all three mela-
nogenic enzymes (tyrosinase/Tyrp1/Dct) (Figs. 1 and 6) and
overexpression of constitutively active Rab32/38 mutants
induced the same phenotype (Fig. 8), the proper activation and
inactivation of Rab32/38 (i.e. GTP-GDP cycling) must be nec-
essary for melanogenic enzyme transport to occur in melano-
cytes (Fig. 12A, control cells, and Fig. 12B, RUTBC1 knock-
down cells). The importance of GTP-GDP cycling of Rab27A in
actin-based melanosome transport in melanocytes has also
recently been reported (33). Thus, in the future it would be
interesting to determine the mechanism by which spatiotem-
poral regulation of Rab32/38 is achieved by RUTBC1 (or
Rab27A by EPI64 (34)) in melanocytes.
Because Rab32, and not Rab38, is reportedly responsible for
the trafficking of Dct in “human” MNT-1 melanoma cells (3),
the discovery in the present study that RUTBC1 and its sub-
strate Rab32/38 are also involved in the trafficking of Dct in
mouse melan-a cells was unexpected (Figs. 1C, 5, A and B, 6, B
and C, and 8I). Although we do not know the reason for this
species difference, the Dct trafficking pathways in human
melanoma cells and mouse melanocytes may be different. In
the future it would be interesting to investigate the differ-
ences between melanogenesis in human and mouse melano-
cytes. At any rate, because the Rab32/38 effector Varp is also
involved in the trafficking of all three melanogenic enzymes
(tyrosinase/Tyrp1/Dct) the same as Rab32/38 (Fig. 5), the
Rab32/38-mediated membrane trafficking pathway is re-
quired for proper tyrosinase/Tyrp1/Dct transport to mela-
nosomes in mouse melanocytes.
Another unexpected finding in our study was that overex-
pression of the full-length GAP activity-deficient RUTBC1
(R803A) mutant in melanocytes also caused a reduction in the
signals of all three melanogenic enzymes, the same as overex-
pression of wild-type RUTBC1 did (Fig. 1), whereas the C-ter-
minal RUTBC1-C(R803A) mutant had no effect at all (Fig. 2).
Because the N-terminal domain of RUTBC1 interacts with
Rab9 (Fig. 1A) (18, 19), the inhibitory effect of the RUTBC1
(R803A) mutant is likely to be caused by trapping endogenous
Rab9A, resulting in inhibition of the endogenous Rab9A-
RUTBC1 interaction in melanocytes. Consistent with this pos-
sibility, no significant difference in tyrosinase signals was
observed when RUTBC1(R803A) was coexpressed together
with Rab9A in melanocytes (Fig. 9A). Rab9 is known to be
expressed ubiquitously and to regulate the transport of the
mannose 6-phosphate receptor from late endosomes to the
trans-Golgi network (35); however, the physiological function
of Rab9 inmelanocytes had never been satisfactorily elucidated.
The results of the present study demonstrate that Rab9A has
the ability to recruit RUTBC1 to melanosomes and that Rab9A
is required for the trafficking of all three melanogenic enzymes
(Fig. 10). Consistent with our results, very recently, during the
course of revising this paper, Mahanty et al. (36) have reported
the involvement of Rab9A in melanogenic enzyme trafficking.
Moreover, we demonstrated that RUTBC1 is able to disrupt the
interaction between Rab9A and HPS4, a component of
BLOC-3, a Rab32/38 GEF (12) (Fig. 11). Thus, RUTBC1 over-
expression inhibits Rab32/38 activation both directly by pro-
FIGURE 11. RUTBC1 competes with HPS4 for binding to Rab9A. COS-7 cell
lysates expressing FLAG-Rab9A or nothing (Mock) together with HA-HPS4
and/or T7-RUTBC1 were immunoprecipitated with anti-FLAG tag antibody-
conjugated agarose beads, and the proteins bound to the beads were ana-
lyzed by immunoblotting with the indicated antibodies. Input, 0.8% volume
of the reaction mixture (third and fourth panels). The positions of the molec-
ular mass markers (in kDa) are shown on the left.
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moting Rab32/38 GAP activity and indirectly by disrupting
the Rab9-HPS4 interaction. RUTBC1 is unlikely to disrupt
the Rab9-HPS4 interaction when RUTBC1 and Rab9A are
coexpressed in melanocytes, because a sufficient amount of
Rab9A is present in the cells and no competition between
RUTBC1 and HPS4 would occur. However, the overex-
pressed RUTBC1 still has the ability to inactivate Rab32/38,
because the Rab32/38 activated by BLOC-3 is rapidly inacti-
vated by the overexpressed RUTBC1 (Fig. 12C). By contrast,
when RUTBC1(R803A) is expressed together with Rab9A,
the Rab9A-HPS4 interaction would occur normally, and
RUTBC1(R803A) cannot inactivate Rab32/38. Actually,
there was no change at all in tyrosinase signals in
Rab9ARUTBC1(R803A)-expressing cells, when compared
withRab9ARUTBC1(WT)-expressing cells (Fig. 9).Our find-
ings suggest that the proper activation of Rab32/38 by Rab9-
BLOC-3 and their subsequent inactivation by Rab9-RUTBC1
(i.e. cycling between GDP-Rab32/38 and GTP-Rab32/38) are
required for melanogenic enzyme trafficking to melanosomes.
Further extensive research will be necessary to determine the
exact mechanism of the coordination between the activation
and inactivation of Rab32/38 by Rab9A.
FIGURE12.ProposedmodelsofRab32/38activationand inactivation inmelanocytes.A, inwild-typecellsRab32/38 is activatedby theRab9effectorBLOC-3, and
GTP-Rab32/38 is then inactivated by another Rab9 effector, RUTBC1, through promoting theGTPase activity of both Rab32 and Rab38. A proper activation-inactiva-
tion cycle between GTP-Rab32/38 and GDP-Rab32/38 is essential for melanogenic enzyme trafficking to melanosomes, as both knockdown of RUTBC1 (see B) and
expression of constitutively active Rab32/38 mutants caused a dramatic reduction in melanogenic enzyme signals (Figs. 6 and 8). To simplify the model, Varp
(Rab32/38 effector) and its cargo (melanogenic enzymes) have not been depicted. B, because Rab32 and Rab38 are constantly activated at the melanosomes in
RUTBC1 knockdown cells,melanogenic enzymes are not properly transported to themelanosomes and, for themost part, are degraded in lysosomes.C, in RUTBC1-
overexpressingcells, RUTBC1 inactivatesRab32andRab38 immediately after activationbyBLOC-3,whichprevent the traffickingofmelanogenicenzymes. If the level
of Rab9A expression is insufficient, RUTBC1 can also disrupt the formation of the Rab9ABLOC-3 complex, which is required for Rab32/38 activation. If the Rab9A
expression level is sufficient because of Rab9A coexpression, RUTBC1(R803A) is unable to disrupt the formation of Rab9ABLOC-3 complex and does not inactivate
Rab32/38 (Fig. 9). Thus,melanogenic enzymes in RUTBC1(R803A)Rab9A-expressing cells are correctly transported tomelanosomes.
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Because RUTBC1 has also been found to possess GAP activ-
ity toward Rab33B in vitro (18), the possibility remains that
RUTBC1 participates in the trafficking of melanogenic
enzymes through the inactivation of Rab33B rather than
Rab32/38. That possibility is very unlikely, however, because of
the following observations. First, in contrast to Rab32/38 being
colocalized well with Tyrp1 (14), most EGFP-tagged Rab33B is
present at the Golgi (37, 38) and not at melanosomes or the
tyrosinase-containing vesicles at the cell periphery (data not
shown). Second, we found that in sharp contrast to the results
of expression of the constitutively active mutants of Rab32/38,
which decreased the signals of all three melanogenic enzymes
(Fig. 8), expression of a constitutively active mutant of
Rab33B(Q92L) affected the signals of the three melanogenic
enzymes differently: it increased the Tyrp1 signals slightly and
had almost no effect on theDct signals, whereas it decreased the
tyrosinase signals (data not shown). Thus, the observed effects
of RUTBC1 knockdown on tyrosinase/Tyrp1/Dct signals are
most likely attributable to excess activation of Rab32/38, rather
than of Rab33B. However, because Rab33B has been shown to
be involved in the autophagosomematuration step (22, 38) and
the retrograde Golgi transport pathway (39), and because
decreased tyrosinase signals were observed in Rab33B(Q92L)-
expressing cells, Rab33B may participate in melanogenic
enzyme trafficking in melanocytes in a different way from
Rab32/38, i.e. by regulating autophagy or retrograde Golgi
transport. It seems noteworthy that an autophagy regulator,
WIPI1, has been shown to regulate the biogenesis of melano-
somes (40). Further investigation of Rab33B in the future
should clarify its function in melanogenesis.
In conclusion, this study is the first to demonstrate that the
Rab9-binding protein RUTBC1 regulates the trafficking of all
three melanogenic enzymes in melanocytes by inactivating
Rab32/38. The results of this study also demonstrated that
excess activation of Rab32/38, either by RUTBC1 knockdown
or by overexpression of Rab32(Q83L)/38(Q69L), inhibits the
trafficking of all three melanogenic enzymes. Our findings sug-
gest that a properGTP-GDP cycle for Rab32/38 is necessary for
the normal trafficking of all three melanogenic enzymes to
melanosomes to occur.
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